BA
TMDI

Ballew Advisors’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Ballew Advisors’s Portfolio TMDI Stock Details TMDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-45
Closed – – 472
2018
Q3 		$0 Buy
+45
New +$127 ﹤0.01% 521

Other funds holding TMDI

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PI
Pathlight Investors Phoenix, Arizona $121M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
SHA
Seneca House Advisors Richmond, Virginia $252M AUM 17.04% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Ballew Advisors's TMDI Position: Q4 2018 in Review

Ballew Advisors sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q4 2018, closing a stake of 45 shares.

Ballew Advisors first reported a position in TMDI in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 43 funds tracked by Wall St. Rank hold TMDI as of Q4 2018.

  • Ballew Advisors reported no remaining Titan Medical Inc. Ordinary Shares position as of Q4 2018 after selling out during the quarter.
  • Ballew Advisors sold 45 Titan Medical Inc. Ordinary Shares shares in Q4 2018.
  • Ballew Advisors first reported a position in Titan Medical Inc. Ordinary Shares in Q3 2018 and held it in 1 quarter.
  • Ballew Advisors's Titan Medical Inc. Ordinary Shares position peaked at $0 in Q3 2018.
  • 43 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q4 2018.

Based on Ballew Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.